These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27318369)

  • 1. Computational analysis of mechanical stress-strain interaction of a bioresorbable scaffold with blood vessel.
    Schiavone A; Abunassar C; Hossainy S; Zhao LG
    J Biomech; 2016 Sep; 49(13):2677-2683. PubMed ID: 27318369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of material, coating, design and plaque composition on stent deployment inside a stenotic artery--finite element simulation.
    Schiavone A; Zhao LG; Abdel-Wahab AA
    Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():479-88. PubMed ID: 25063145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finite element evaluation of artery damage in deployment of polymeric stent with pre- and post-dilation.
    He R; Zhao LG; Silberschmidt VV; Liu Y; Vogt F
    Biomech Model Mechanobiol; 2020 Feb; 19(1):47-60. PubMed ID: 31317295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Computational Study of Mechanical Performance of Bioresorbable Polymeric Stents with Design Variations.
    Qiu TY; Zhao LG; Song M
    Cardiovasc Eng Technol; 2019 Mar; 10(1):46-60. PubMed ID: 30536211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
    Serruys PW; Chevalier B; Dudek D; Cequier A; Carrié D; Iniguez A; Dominici M; van der Schaaf RJ; Haude M; Wasungu L; Veldhof S; Peng L; Staehr P; Grundeken MJ; Ishibashi Y; Garcia-Garcia HM; Onuma Y
    Lancet; 2015 Jan; 385(9962):43-54. PubMed ID: 25230593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
    Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D
    JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.
    Muramatsu T; Onuma Y; García-García HM; Farooq V; Bourantas CV; Morel MA; Li X; Veldhof S; Bartorelli A; Whitbourn R; Abizaid A; Serruys PW;
    JACC Cardiovasc Interv; 2013 Mar; 6(3):247-57. PubMed ID: 23517836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
    Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ;
    JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.
    Onuma Y; Serruys PW; Gomez J; de Bruyne B; Dudek D; Thuesen L; Smits P; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia H; Ormiston JA;
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):3-12. PubMed ID: 21413120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
    Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B
    Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials.
    Brugaletta S; Gomez-Lara J; Diletti R; Farooq V; van Geuns RJ; de Bruyne B; Dudek D; Garcia-Garcia HM; Ormiston JA; Serruys PW
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):219-28. PubMed ID: 21563288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulnerability analysis on the interaction between Asymmetric stent and arterial layer.
    Syaifudin A; Ariatedja JB; Kaelani Y; Takeda R; Sasaki K
    Biomed Mater Eng; 2019; 30(3):309-322. PubMed ID: 31127751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A computational study of crimping and expansion of bioresorbable polymeric stents.
    Qiu TY; Song M; Zhao LG
    Mech Time Depend Mater; 2018; 22(2):273-290. PubMed ID: 29962898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition).
    Ormiston JA; Webber B; Ubod B; Darremont O; Webster MW
    EuroIntervention; 2015 May; 11(1):60-7. PubMed ID: 25680225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial.
    Chevalier B; Onuma Y; van Boven AJ; Piek JJ; Sabaté M; Helqvist S; Baumbach A; Smits PC; Kumar R; Wasungu L; Serruys PW
    EuroIntervention; 2016 Oct; 12(9):1102-1107. PubMed ID: 27564310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue prolapse and stresses in stented coronary arteries: A computer model for multi-layer atherosclerotic plaque.
    Hajiali Z; Dabagh M; Debusschere N; De Beule M; Jalali P
    Comput Biol Med; 2015 Nov; 66():39-46. PubMed ID: 26378501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials.
    Gogas BD; Bourantas CV; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Diletti R; van Geuns RJ; De Bruyne B; Chevalier B; Thuesen L; Smits PC; Dudek D; Koolen J; Windecker S; Whitbourn R; McClean D; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Ormiston JA; Serruys PW
    EuroIntervention; 2013 Oct; 9(6):709-20. PubMed ID: 23628499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of stent design and atherosclerotic plaque composition on arterial wall biomechanics.
    Timmins LH; Meyer CA; Moreno MR; Moore JE
    J Endovasc Ther; 2008 Dec; 15(6):643-54. PubMed ID: 19090628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential Proximal Optimizing Technique in Provisional Bifurcation Stenting With Everolimus-Eluting Bioresorbable Vascular Scaffold: Fractal Coronary Bifurcation Bench for Comparative Test Between Absorb and XIENCE Xpedition.
    Derimay F; Souteyrand G; Motreff P; Guerin P; Pilet P; Ohayon J; Darremont O; Rioufol G; Finet G
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1397-406. PubMed ID: 27388830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.